✦ LIBER ✦

A phase II study of a modified cisplatin and gemcitabine regimen in advanced non-small cell lung cancer (NSCLC): preliminary results

✍ Scribed by Gonzalez-Martin, A; Garcia-Lopez, JL; Crespo, C; Lastra, E; Pedraza, M; Rios, A; Moyano, A; Garrido, P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biweekly gemcitabine in two hours infusi

✍ I. Chacon; I. Garcia-Carbonero; L. Lopez; J. Andrade; B. Martinez; M. Cruz-Mora 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Phase II trial assessing the combination

✍ Antón, A; Dı́az-Fernández, N; González Larriba, J.L; Vadell, C; Masutti, B; Mont 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 91 KB

A phase II study of cisplatin-gemcitabin

✍ Vázquez, F; Barón, FJ; Cueva, JF; Candamio, S; Calvo, M; Irigoyen, A; Huidobro, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Phase II study with gemcitabine, ifosfam

✍ Chen, Yuh-Min; Perng, Reury-Perng; Whang-Peng, Jacqueline; Wu, Hsiao-Wei; Lin, W 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Gemcitabine-cisplatin (GP) vs gemcitabin

✍ P. Mazzanti; C. Massacesi; R. Mattioli; R. Trivisonne; F. Buzzi; G. De Signoribu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Gemcitabine monotherapy in the elderly p

✍ Antonuzzo, A; Galli, L; Ricci, S; Tibaldi, C; Bertuccelli, M; Petruzzelli, S; Ta 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 128 KB